생화학분자생물학회입니다.
| No. | Vol | Subject | Hit |
|---|---|---|---|
| 185 | 2020/12 (Dec) | Update of Early Phase Clinical Studies in Cancer Immunotherapy | 2 |
| 184 | 2020/12 (Dec) | Genome editing of immune cells using the CRISPR/Cas system | 1 |
| 183 | 2020/12 (Dec) | Dendritic cells in cancer immunology | 1 |
| 182 | 2020/12 (Dec) | Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors | 1 |
| 181 | 2020/12 (Dec) | Cancer Immunotherapy with T-cell targeting cytokines: IL-2 and IL-7 | 1 |
| 180 | 2020/12 (Dec) | Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy | 1 |
| 179 | 2020/12 (Dec) | Current understanding on cancer-intrinsic PD-L1: regulation of expression and its protumoral activity | 1 |
| 178 | 2020/11 (Nov) | Substrate specificity of bacterial endoribonuclease toxins | 2 |
| 177 | 2020/11 (Nov) | Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy | 1 |
| 176 | 2020/11 (Nov) | Epitranscriptomic regulation of transcriptome plasticity in development and diseases of the brain | 1 |